Literature DB >> 10981652

Chronic intestinal pseudo-obstruction in systemic lupus erythematosus due to intestinal smooth muscle myopathy.

P A Hill1, K M Dwyer, D A Power.   

Abstract

We report the case of a woman with systemic lupus erythematosus initially manifesting with fever, rash and arthritis, and two years later with Class IV lupus nephritis. Following treatment with cyclophosphamide she developed symptoms and signs of chronic intestinal pseudo-obstruction (CIPO) that was initially thought to be due to a neutropenic enterocolitis. However, persistence of symptoms resulted in segmental resection of the ileum which showed widespread myocyte necrosis and active inflammation within the muscularis propria. A subsequent, more extensive ileocolic resection showed severe diffuse atrophy and fibrosis of the muscularis propria throughout the resected bowel. The absence of mesenteric vasculitis and the clinical response of the CIPO to the immunosupressive regimen of prednisolone and cyclosporin A suggest that the bowel muscle coat changes reflect an intestinal myopathy secondary to systemic lupus erythematosus, and may have an auto-immune etiology.

Entities:  

Mesh:

Year:  2000        PMID: 10981652     DOI: 10.1191/096120300678828505

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  13 in total

1.  Smooth-Muscle Myopathy in Systemic Lupus Erythematosus Presenting With Intestinal Pseudo-Obstruction.

Authors:  Chen Yang; Simon Chen; Joseph P Gaut; Louis P Dehner
Journal:  Am J Gastroenterol       Date:  2016-10       Impact factor: 10.864

Review 2.  Visceral muscle dysmotility syndrome in systemic lupus erythematosus: case report and review of the literature.

Authors:  Yu Qiang Chen; Qing Xue; Nian Song Wang
Journal:  Rheumatol Int       Date:  2011-03-24       Impact factor: 2.631

3.  Generalized megaviscera of lupus: refractory intestinal pseudo-obstruction, ureterohydronephrosis and megacholedochus.

Authors:  Frederick-D Park; Jeffrey-K Lee; Ganga-D Madduri; Pradipta Ghosh
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

Review 4.  Reports of three cases with the initial presentation of mesenteric vasculitis in children with system lupus erythematous.

Authors:  Yuan Liu; Jia Zhu; Jian Ming Lai; Xue Feng Sun; Jun Hou; Zhi Xuan Zhou; Xin Yu Yuan
Journal:  Clin Rheumatol       Date:  2017-10-10       Impact factor: 2.980

5.  Immune-mediated necrotizing myopathy, associated with antibodies to signal recognition particle, together with lupus nephritis: case presentation and management.

Authors:  John O'Grady; Len Harty; Nick Mayer; Val Critcher; John Ryan
Journal:  J Clin Med Res       Date:  2015-04-08

6.  Intestinal Pseudo-Obstruction as an Initial Manifestation of Systemic Lupus Erythematosus.

Authors:  Dong Jun Oh; Jae Nam Yang; Yun Jeong Lim; Ji Hyuk Kang; Jung Hyun Park; Mal Young Kim
Journal:  Intest Res       Date:  2015-06-09

Review 7.  Intestinal pseudo-obstruction in systemic lupus erythematosus: a case report and review of the literature.

Authors:  Jian-Lin Wang; Gang Liu; Tong Liu; Jiang-Peng Wei
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

8.  Clinical analysis of 61 systemic lupus erythematosus patients with intestinal pseudo-obstruction and/or ureterohydronephrosis: a retrospective observational study.

Authors:  Na Xu; Jiuliang Zhao; Jinjing Liu; Di Wu; Lidan Zhao; Qian Wang; Yong Hou; Mengtao Li; Wen Zhang; Xuejun Zeng; Weigang Fang; Xiaoming Huang; Xuan Zhang; Xinping Tian; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

9.  Lupus intestinal pseudo-obstruction and hydronephrosis: Case report.

Authors:  Brittany L Adler; Homa Timlin; Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

10.  Acute lupus pneumonitis followed by intestinal pseudo-obstruction in systemic lupus erythematosus: A case report.

Authors:  Caihong Ji; Xing Yu; Yong Wang; Lufeng Shi
Journal:  Exp Ther Med       Date:  2016-05-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.